379 related articles for article (PubMed ID: 15522165)
21. [Single nucleotide polymorphism in the matrix metalloproteinases promoter is associated with susceptibility to endometriosis and adenomyosis].
Kang S; Wang Y; Zhang JH; Jin X; Fang SM; Li Y
Zhonghua Fu Chan Ke Za Zhi; 2005 Sep; 40(9):601-4. PubMed ID: 16202315
[TBL] [Abstract][Full Text] [Related]
22. [Correlation of XPC Ala499Val and Lys939Gln polymorphisms to risks of esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma].
Zhou RM; Li Y; Wang N; Zhang XJ; Dong XJ; Guo W
Ai Zheng; 2006 Sep; 25(9):1113-9. PubMed ID: 16965652
[TBL] [Abstract][Full Text] [Related]
23. No association between the C-1562T polymorphism in the promoter of matrix metalloproteinase-9 gene and non-small cell lung carcinoma.
Wang Y; Fang S; Wei L; Wang R; Jin X; Wen D; Li Y; Guo W; Wang N; Zhang J
Lung Cancer; 2005 Aug; 49(2):155-61. PubMed ID: 15949868
[TBL] [Abstract][Full Text] [Related]
24. Association of heparanase gene (HPSE-1) single nucleotide polymorphisms with gastric cancer.
Yue Z; Song Y; Wang Z; Luo Y; Jiang L; Xing L; Xu H; Zhang X
J Surg Oncol; 2010 Jul; 102(1):68-72. PubMed ID: 20578081
[TBL] [Abstract][Full Text] [Related]
25. [Association of TP53 gene polymorphisms with genetic susceptibility to liver metastases of colorectal cancer].
Wang AZ; Zhu ZZ; Cong WM
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Apr; 25(2):168-71. PubMed ID: 18393238
[TBL] [Abstract][Full Text] [Related]
26. Genetic polymorphism c.1562C>T of the MMP-9 is associated with macroangiopathy in type 2 diabetes mellitus.
Wang Y; Su Y; Xu Y; Pan SH; Liu GD
Biochem Biophys Res Commun; 2010 Jan; 391(1):113-7. PubMed ID: 19909726
[TBL] [Abstract][Full Text] [Related]
27. The association of MMP-9 and IL-18 gene promoter polymorphisms with gingivitis in adolescents.
Vokurka J; Klapusová L; Pantuckova P; Kukletova M; Kukla L; Holla LI
Arch Oral Biol; 2009 Feb; 54(2):172-8. PubMed ID: 18930181
[TBL] [Abstract][Full Text] [Related]
28. Clinicopathological significance of MMP-2 and TIMP-2 genotypes in gastric cancer.
Wu CY; Wu MS; Chen YJ; Chen CJ; Chen HP; Shun CT; Chen GH; Huang SP; Lin JT
Eur J Cancer; 2007 Mar; 43(4):799-808. PubMed ID: 17236757
[TBL] [Abstract][Full Text] [Related]
29. Matrix metalloproteinase-1, -3, and -9 gene polymorphisms and the risk of idiopathic dilated cardiomyopathy in a Chinese Han population.
Tang LJ; Chen XF; Zhu M; Jiang JJ; Lu XB; Du YX; Wang B; Fang CF; Xue YS; Shen WF
Clin Biochem; 2007 Dec; 40(18):1427-30. PubMed ID: 18028894
[TBL] [Abstract][Full Text] [Related]
30. Matrix metalloproteinases 1, 2, 3 and 9 functional single-nucleotide polymorphisms in idiopathic recurrent spontaneous abortion.
Pereza N; Ostojić S; Volk M; Kapović M; Peterlin B
Reprod Biomed Online; 2012 May; 24(5):567-75. PubMed ID: 22406112
[TBL] [Abstract][Full Text] [Related]
31. Functional polymorphisms and haplotypes in the promoter of the MMP2 gene are associated with risk of nasopharyngeal carcinoma.
Zhou G; Zhai Y; Cui Y; Qiu W; Yang H; Zhang X; Dong X; He Y; Yao K; Zhang H; Peng Y; Yuan X; Zhi L; Zhang X; He F
Hum Mutat; 2007 Nov; 28(11):1091-7. PubMed ID: 17607721
[TBL] [Abstract][Full Text] [Related]
32. The role of genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes in head and neck cancer.
O-Charoenrat P; Khantapura P
Oral Oncol; 2006 Mar; 42(3):257-67. PubMed ID: 16275157
[TBL] [Abstract][Full Text] [Related]
33. Substantial reduction in risk of breast cancer associated with genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes.
Zhou Y; Yu C; Miao X; Tan W; Liang G; Xiong P; Sun T; Lin D
Carcinogenesis; 2004 Mar; 25(3):399-404. PubMed ID: 14604886
[TBL] [Abstract][Full Text] [Related]
34. Meta-analysis of association between matrix metalloproteinases 2, 7 and 9 promoter polymorphisms and cancer risk.
Peng B; Cao L; Ma X; Wang W; Wang D; Yu L
Mutagenesis; 2010 Jul; 25(4):371-9. PubMed ID: 20360147
[TBL] [Abstract][Full Text] [Related]
35. Functional haplotypes in the promoter of matrix metalloproteinase-2 and lung cancer susceptibility.
Zhou Y; Yu C; Miao X; Wang Y; Tan W; Sun T; Zhang X; Xiong P; Lin D
Carcinogenesis; 2005 Jun; 26(6):1117-21. PubMed ID: 15731163
[TBL] [Abstract][Full Text] [Related]
36. [Analysis of the gene polymorphism of matrix metalloproteinase-2 and -9 in patients with coronary heart disease].
Shevchenko AV; Golovanova OV; Konenkov VI; Tolkacheva OM; Maksimov VN; Voevoda MI; Romashchenko AG
Ter Arkh; 2010; 82(1):31-4. PubMed ID: 20364697
[TBL] [Abstract][Full Text] [Related]
37. Matrix metalloproteinase-1 and -9 promoter polymorphisms are not associated with an increased risk of uterine leiomyomas in a Japanese population.
Takemura N; Yoshida S; Kennedy S; Deguchi M; Ohara N; Maruo T
J Soc Gynecol Investig; 2006 Apr; 13(3):232-6. PubMed ID: 16638593
[TBL] [Abstract][Full Text] [Related]
38. Clinical implications of matrix metalloproteinase-1, -3, -7, -9, -12, and plasminogen activator inhibitor-1 gene polymorphisms in colorectal cancer.
Woo M; Park K; Nam J; Kim JC
J Gastroenterol Hepatol; 2007 Jul; 22(7):1064-70. PubMed ID: 17608852
[TBL] [Abstract][Full Text] [Related]
39. Host single nucleotide polymorphisms of MMP-9 -1562/TIMP-1 372 have gender differences in the risk of gastric intestinal metaplasia after Helicobacter pylori infection.
Hung KH; Hung HW; Yang HB; Lu CC; Wu JJ; Sheu BS
Helicobacter; 2009 Dec; 14(6):580-7. PubMed ID: 19889076
[TBL] [Abstract][Full Text] [Related]
40. [Association of CASP3 and CASP9 polymorphisms with genetic susceptibility to stomach cancer].
Ni Q; Jiang X; Jin MJ; Liu B; Chen K
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2011 Jun; 28(3):318-22. PubMed ID: 21644232
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]